Orbital raises $270 million to develop gene-based drugs and vaccines

The Cambridge startup’s successful first fund-raising round defies the biotech industry’s slump.

Related Keywords

Alexandria ,Al Iskandariyah ,Egypt ,Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Redmile ,Leicestershire ,Abu Dhabi ,Abuz Aby ,United Arab Emirates ,Chicago ,Illinois ,John Maraganore ,Giuseppe Ciaramella ,Kristina Burow ,Alnylam Pharmaceuticals ,University Of Pennsylvania Perelman School Medicine ,Abu Dhabi Growth Fund ,Redmile Group ,Globe Platinum Fund Group ,Drug Administration ,Pfizer ,Cambridge Based Moderna ,Nobel Prize Winning ,Drew Weissman ,Pennsylvania Perelman School ,Beam Therapeutics ,South San ,Newpath Partners ,Moore Strategic Ventures ,Casdin Capital ,Agent Capital ,Alexandria Venture Investments ,Rellim Capital Management ,Heritage Medical Systems , ,